Tuesday, 18 June 2019

Compared with insulin glargine, initial injectable therapy with a combination of insulin degludec and liraglutide aids achievement of blood glucose goals for a longer period of time in patients with uncontrolled type 2 diabetes on oral antidiabetic drugs, according to a study published online June 9 in The Lancet Diabetes & Endocrinology to coincide with the annual meeting of the American Diabetes Association, held from June 7 to 11 in San Francisco.


Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)


Posted by at

1 comment:

  1. Cawka22 June 2019 at 00:22

    Radiation treatment for cancer can damage the heart and blood vessels, increasing the risk for a stroke or heart attack. But a new study suggests cholesterol-lowering drugs can significantly reduce that risk.

    ReplyDelete

Subscribe to: Post Comments (Atom)